Victor Bultó

Victor Bulto is President of the US unit for Novartis, pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.

Bultó is driven by the pressing need to translate medicines to outcomes – at scale and equitably – and transform the patient experience to help mitigate the challenges people living with disease face in getting diagnosed, obtaining medicine, and staying on treatment within the complex US healthcare system.

Prior to this role, Bultó served as President, Novartis Pharmaceuticals Corporation, leading the US pharmaceuticals business. He has been with Novartis for 19 years and has broad, multinational experience in the healthcare industry. He has worked across every therapeutic area at Novartis Pharmaceuticals and played critical roles in launching numerous products.

Bultó has held various other positions at Novartis, including Head of the US Alcon Pharmaceuticals Franchise and Head of the Neuroscience Franchise for Region Europe, where he had responsibility for the overall strategy, growth and profitability of these businesses. Before joining Novartis, Bultó was a medical device sales representative.

He has a strong track-record as a people-first leader with a focus on creating a culture where each individual can show up every day as their authentic self to best serve the interests of people living with disease.